SLS Depreciation & Amortization
Sellas Life Sciences Group Inc · Depreciation & Amortization
SLS Depreciation & Amortization
Latest reported$7.08Mperiod ending
SLS TTM Depreciation & Amortization ($36.00K → $7.08M)
TTM Depreciation & Amortization
High-resolution chart · PNG
SLS depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 7,083,000 | |
| 7,083,000 | |
| 7,083,000 | |
| 7,083,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 158,000 | |
| 158,000 | |
| 281,000 | |
| 488,000 | |
| 412,000 | |
| 457,000 | |
| 1,607,000 | |
| 1,400,000 | |
| 1,318,000 | |
| 2,119,000 | |
| 923,000 | |
| 923,000 | |
| 923,000 | |
| 77,000 | |
| 4,646,000 | |
| 4,746,000 | |
| 4,846,000 | |
| 4,946,000 | |
| 9,438,000 | |
| 9,338,000 | |
| 9,238,000 | |
| 14,822,000 | |
| 5,608,000 | |
| 5,633,000 | |
| 5,658,000 | |
| 0 | |
| -1,157,000 | |
| -584,000 | |
| -550,000 | |
| -503,000 | |
| 781,000 | |
| 306,000 | |
| 330,000 | |
| 355,000 | |
| 528,000 | |
| 609,000 | |
| 755,000 | |
| 889,000 | |
| 949,000 | |
| 872,000 | |
| 682,000 | |
| 452,000 | |
| 170,000 | |
| 46,000 | |
| 9,000 | |
| 49,000 | |
| 84,000 | |
| 123,000 | |
| 168,000 | |
| 163,000 | |
| 171,000 | |
| 171,000 | |
| 167,000 | |
| 172,000 | |
| 167,000 | |
| 167,000 | |
| 166,000 | |
| 162,000 | |
| 160,000 | |
| 149,000 | |
| 140,000 | |
| 131,000 | |
| 111,000 | |
| 86,000 | |
| 59,000 | |
| 36,000 | |
| 18,000 |